Back to Results
First PageMeta Content
Science / Medical terms / Bioethics / Medical ethics / Mind-body interventions / Adverse effect / Pharmacovigilance / Placebo / Nocebo / Medicine / Health / Pharmacology


BMJ 2014;349:g5019 doi: [removed]bmj.g5019 (Published 12 August[removed]Page 1 of 7 Analysis
Add to Reading List

Document Date: 2014-09-12 12:29:51

Open Document

File Size: 1,73 MB

Share Result on Facebook

City

Goh / Tinetti / Thompson / Auckland / Yang / Diefenbach / /

Company

Andrew Grey / GE / Fracture Intervention Trial Research Group / BMJ Publishing Group Ltd / Pilkington / Yahoo / /

Country

Netherlands / New Zealand / /

/

Event

Person Communication and Meetings / /

Facility

University of Auckland / National Library of Medicine / /

IndustryTerm

pharmaceutical company leaflets / treatment for osteoporosis / pharmaceutical / osteoporosis therapy / drug information site / treatment of chronic diseases / /

MedicalCondition

JE / headache / nausea / fatigue / drowsiness / esophageal cancer / back pain / congestive heart failure / peptic ulcer / hypertension / disease / hypothyroidism / chronic / diabetes / sexual dysfunction / ischaemic heart disease / pain / heart failure / chronic disease / diseases / osteoporosis / dizziness / depression / /

MedicalTreatment

oral contraceptives / contraception / /

OperatingSystem

VMS / /

Organization

Medicines and Medical Devices Safety Authority / American Society of Health System Pharmacists Outcomes / New Zealand Government / European Union / University of Auckland / /

Person

Cooper V / Ann Intern Med / Arch Intern Med / Kate Faasse / Ann Pharmacother / /

Position

Prime Minister / WB / Petrie professor / author / MP / Borus JF / associate professor / /

Product

Pioglitazone / simvastatin / Finasteride / Omeprazole / Fluoxetine / Levonorgestrel / lisinopril / Clopidogrel / /

ProvinceOrState

Kentucky / Saskatchewan / South Carolina / Massachusetts / /

Technology

search engine / /

URL

http /

SocialTag